• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE XPEDITION; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE XPEDITION; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1070300-48
Device Problems Stretched (1601); Material Deformation (2976)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/15/2019
Event Type  Injury  
Manufacturer Narrative
Exemption number e2019001.The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation was unable to determine a conclusive cause for the reported material deformation; however, factors that could contribute to material deformation include, but are not limited to, interaction with accessory devices, interaction with patient anatomical morphology, patient disease state and product damage during handling by user.The reported additional therapy/non-surgical treatment appears to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.The xience xpedition 48 is currently not commercially available in the u.S.; however, it is similar to a device sold in the u.S.
 
Event Description
It was reported that the procedure was performed to treat a de novo left anterior descending lesion that was 90% stenosed.Pre-dilatation was done with an unspecified 2.5x15mm balloon at 22-26 atmospheres (atm).A 3.0x48mm xience xpedition stent was deployed at 10atm.Post dilatation was done with a 3.0x15mm non-abbott balloon at 16-24atm.Then the xience xpedition stent was noted to be stretched at the proximal end for about 5-6mm.The stretched portion was post dilated with a 4.0x15mm non-abbott balloon at 14-20atm then with a 4.5x10mm unspecified nc balloon at 20atm.There was no adverse patient sequela and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
A cine was received and reviewed by an abbott vascular clinical research specialist and two cardiologists.The conclusion of the reported stent elongation is inconclusive on the basis of available evidence.Stent elongation may be associated with premature withdrawal of either the stent delivery system or a postdilatation device before full deflation has occurred, especially in circumstances where the stent is either under expanded or incompletely apposed to the vessel wall.Stent elongation is very rarely due to device malfunction/deficiency, but (as the compliant report summary says) more usually associated with interaction between the native vessel architecture, the stent and any post-stent devices passed into the coronary.The finding of stent elongation can be confirmed sometimes angiographically, but more often (to be sure), intracoronary imaging may be required to be absolutely certain.The investigation was unable to determine a conclusive cause for the reported stretched stent (stent elongation.There is no indication of a product quality issue with respect to manufacture, design or labeling.H6: removed device code 2976 and replaced with 1601; removed results code 114 and replaced with 3221.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9570203
MDR Text Key178347782
Report Number2024168-2020-00501
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 03/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/09/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/17/2022
Device Catalogue Number1070300-48
Device Lot Number9060641
Was Device Available for Evaluation? No
Date Manufacturer Received02/17/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
NC SAPPHIRE 3.0X15MM
Patient Outcome(s) Required Intervention;
-
-